UK markets close in 3 hours 17 minutes

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.50+0.02 (+0.24%)
At close: 04:00PM EDT
8.32 -0.18 (-2.12%)
Pre-market: 08:10AM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
48,886
23,028
135,082
19,886
13,469
Operating expenses
Research development
79,523
82,701
107,851
113,820
75,531
Selling general and administrative
34,184
29,285
21,749
17,657
15,238
Total operating expenses
113,834
112,111
129,697
131,565
90,851
Operating income or loss
-67,029
-89,083
5,385
-111,679
-77,382
Total other income/expenses net
679
642
2,334
4,490
2,980
Income before tax
-66,350
-88,441
7,719
-107,189
-74,402
Income tax expense
-
0
-691
-816
-389
Income from continuing operations
-66,350
-88,441
8,410
-106,373
-74,013
Net income
-66,350
-88,441
8,410
-106,373
-74,013
Net income available to common shareholders
-66,350
-88,441
8,410
-106,373
-74,013
Basic EPS
-
-1.74
0.18
-2.49
-2.06
Diluted EPS
-
-1.74
0.18
-2.49
-2.06
Basic average shares
-
50,719
47,413
42,669
35,893
Diluted average shares
-
50,719
47,915
42,669
35,893
EBITDA
-
-88,835
5,594
-111,481
-77,012